Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)

NCT00027079 is registered in ClinicalTrials.gov with National Institute on Alcohol Abuse and Alcoholism (NIAAA) as lead sponsor.

NCT NCT00027079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00027079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2001
Completion date
August 31, 2004
Enrollment
360
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholism